Navigation Links
Two-Year Follow up Data of NuBac® IDE Feasibility Study Was Presented at SAS Meeting
Date:6/1/2010

MARQUETTE, Mich., June 1 /PRNewswire/ -- Pioneer Surgical Technology, Inc. is pleased to announce that the clinical results of the two-year follow up on the NuBac IDE feasibility study patients was presented at the recent 10th annual meeting of The International Society for the Advancement of Spine Surgery (SAS) in New Orleans by Domagoj Coric, M.D., Chief, Department of Neurosurgery, Carolina's Medical Center.

The NuBac implant system is the only Nucleus Replacement device that utilizes an articulating inner ball and socket design that seeks to achieve load sharing and uniform stress distribution under various physiological loading conditions. The NuBac implant is made of PEEK-OPTIMA® material which offers well established biocompatibility, biodurability, excellent wear resistance and radiolucency.

Dr. Coric, a Principal Investigator of the NUBAC IDE study, states, "The 2-year follow up results on the feasibility study patients are very impressive. From a safety point, there were no implant expulsions in this study; which has been the main challenge for all other nucleus devices. I am pleased with the improvements I have seen in these patients' clinical outcomes as well."

NuBac became the first nucleus replacement device to gain FDA IDE pivotal study approval. Pioneer started the pivotal study early last year and has 20 study sites with over 40 investigators across the country. Chip Bao, PhD., Pioneer's CTO, states, "The enthusiasm we have received from the spine surgeons reflects their desire for a less invasive and less bridge-burning motion preservation device. This study will help us understand if we can meet their expectations. We are very fortunate to have so many prominent spine surgeons, both in private practice and major academic institutions, willing to participate in this IDE pivotal study."

Pioneer continues to market their other P3® motion preservation products in Europe; including the NuNec® artificial cervical disc and the BacJac® interspinous decompression device. "The results from our European experience give us a lot of excitement as we strive to enter the U.S. market with these products," states Dr. Bao.

About Pioneer Surgical Technology, Inc.

Pioneer® Surgical Technology, Inc. is a dynamic medical device firm founded in 1992. Pioneer's focus on innovation has resulted in over 130 U.S. and foreign patents, with numerous patents pending. The company has a comprehensive portfolio of orthopedic, spine and biologic systems. Pioneer entered the orthobiologics market with two acquisitions in 2007. Our Orthopaedic, Spine, and Biologic Divisions produce state of the art, cost-effective solutions for surgical procedures that have proven difficult or problematic for both surgeons and patients. Pioneer employs more than 270 people worldwide. For more information on Pioneer and its products visit www.pioneersurgical.com.


'/>"/>
SOURCE Pioneer Surgical Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont
2. OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer
3. Pepsi Urged to Follow Example of Coca-Cola and Stop Hiding Corporate Donations
4. HSC Trial Shows Continued Significant Hair Growth at One Year Follow-up
5. NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company
6. China Integrated Energy, Inc. Announces Eight Million Share Public Follow-On Offering
7. Alexandria Real Estate Equities, Inc. Announces Public Follow-on Offering of 3,000,000 Shares of Common Stock
8. Model predicts evolution of Mediterranean landscape following fires
9. Signostics Closes Follow-On Financing of US$4 Million, Expands Board of Directors
10. Alexandria Real Estate Equities, Inc. Announces Pricing of Public Follow-On Offering of 7,000,000 Shares of Common Stock
11. Corn Growers Reminded to Follow Refuge Requirements as Spring Planting Nears
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016 Australian-US drug discovery ... announced today the appointment of a new Chairman, Mr ... Carmine , effective immediately. James Garner , ... Executive Director and former Acting CEO, Mr Iain Ross ... Non-Executive Director. --> James Garner , has also ...
(Date:2/4/2016)... Falls Church, VA (PRWEB) , ... ... ... a first-year cybersecurity conference presented by Bloomsburg University’s Digital Forensics Club, takes ... Bloomsburg, PA. The two-day event features 20+ speakers and activities such as ...
(Date:2/4/2016)... ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... be held February 8-9, 2016, at the Waldorf Astoria ... & Healthcare Conference, taking place in New ... James Sapirstein , Chief Executive Officer of ContraVir, will ...
(Date:2/4/2016)... ... , ... Many of the engineers at FireflySci, Inc. have been manufacturing quartz ... from other cuvette manufacturers is their supercharged customer service and their extensive database of ... steady flow of inside information, they have recently revamped their manufacturing techniques to reduce ...
Breaking Biology Technology:
(Date:2/3/2016)... , Feb. 3, 2016 ... the addition of the "Emotion Detection ... Machine Learning, and Others), Software Tools (Facial ... Areas, End Users,and Regions - Global forecast ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has ...
(Date:2/2/2016)... 2, 2016   Parabon NanoLabs (Parabon) ... Army Research Office and the Defense Forensics and ... of the company,s Snapshot Kinship Inference ... more generally, defense-related DNA forensics.  Although Snapshot is ... appearance and ancestry from DNA evidence), it also ...
(Date:1/28/2016)... Jan. 28, 2016 Synaptics (NASDAQ: SYNA ), a ... its second quarter ended December 31, 2015. ... of fiscal 2016 increased 2 percent compared to the comparable quarter ... of fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... income for the first quarter of fiscal 2016 grew 9 percent ...
Breaking Biology News(10 mins):